Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000534589 | SCV000636572 | benign | Kleefstra syndrome 1 | 2024-11-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000534589 | SCV000895980 | uncertain significance | Kleefstra syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395355 | SCV002701366 | likely benign | Inborn genetic diseases | 2017-08-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000534589 | SCV003831849 | uncertain significance | Kleefstra syndrome 1 | 2019-11-25 | criteria provided, single submitter | clinical testing |